Advanced Data-Visualization for Drug Discovery

Download Report

Transcript Advanced Data-Visualization for Drug Discovery

Using Spotfire DecisionSite to Realize the Full Value of High-Throughput Screening ADME Data

Eric Milgram

Pfizer Global Research & Development – La Jolla Spotfire Users’ Group Meeting Wednesday October 15, 2003 San Francisco, California

Challenge faced by Pharmaceutical Industry

$25

Cost and Number of NDAs per year

$20

Reduce Attrition $15

Increase Productivity $10

No growth $5

Budgetary Pressure $0 1970197119721973197419751976197719781979198019811982198319841985198619871988198919901991199219931994199519961997199819992000

Source: PhRMA annual survey, 2000

Why Do Candidates Fail?

Commercial Reasons Miscellaneous 198 NCEs Adverse effects in man 10% 5% 5% Animal Toxicity 11% 39% Pharmacokinetics 30%

Drug Discovery Today 2:436, 1997

Lack of Efficacy

The Fate of a Medication after Administration ADME

• • • • Absorption • The movement of drugs into the bloodstream or lymphatic system from the site of administration Distribution • The distribution of absorbed drugs from the absorption site to all areas of the body Metabolism • The biotransformation of drugs to more polar forms (hydrolysis, oxidation, conjugation, etc.) Excretion • The elimination of “unwanted” substances

Drug Metabolism in Drug Discovery

• Early assessment is critical, since the duration of action is dependent on structural modifications induced by

in vivo

metabolizing systems.

• Early knowledge of metabolic products permits metabolism guided structure modification schemes, such as modification of metabolic “soft spots” to achieve prolonged drug action.

• Identify pharmacologically or toxicologically active metabolites.

Physicochemical & Biochemical In- Vitro Assays

Predictive of

In-Vivo

Absorption, Distribution, Metabolism, Excretion • Solution Properties • • Solubility Log D • Protein Binding • pKa • Absorption • • PAMPA Caco-2, MDCK • P gp transport • IAM • Metabolism • Metabolic stability •

Liver microsomes hepatocytes , S-9,

• • Metabolic profile CYP450 enzyme inhibition • Safety Assessment • Cell viability • Mutagenesis (Ames) • • Glutathione level Dofetilide binding

Pritchard, et al., “Making Better Drugs: Decision Gates in Non-Clinical Drug Development” Nature Reviews: Drug Discovery, 2003 , vol 2(7), pp. 542-553. (http://www.nature.com/reviews/)

Advances in Laboratory Robotics and Instrumentation Have Been Swift

Difficulties Resulting from HTS

 The rate at which we can collect data far exceeds our capacity to transform this data into information that can be used most effectively to drive important business decisions    Relevance of data?

Number of data dimensions?

What do we do when two different dimensions are in conflict?

 Unmasking subtleties (ie “data-mining”)

Visualization is a Powerful Tool For Data Analysis

Spotfire can be used to find trends related to how samples are formatted on plates.

PLATE_NUMBER - 1 H G F E D C B A H G F E D C B A H G F E D C B A H G F E D C B A PLATE_NUMBER - 6 PLATE_NUMBER - 11 PLATE_NUMBER - 16 2 4 6 8 10 12 PLATE_NUMBER - 2 PLATE_NUMBER - 7 PLATE_NUMBER - 12 PLATE_NUMBER - 23 Scatter Plot PLATE_NUMBER - 3 PLATE_NUMBER - 8 PLATE_NUMBER - 13 PLATE_NUMBER - 24 PLATE_NUMBER - 4 PLATE_NUMBER - 9 PLATE_NUMBER - 14 PLATE_NUMBER - 5 PLATE_NUMBER - 10 PLATE_NUMBER - 15 2 4 6 8 10 12 2 4 6 8 WELL_COLUMN 10 12 2 4 6 8 10 12 2 4 6 8 10 12

Figure 3.

Spotfire plot of variation in the internal standard for a series

How do we use Spotfire DecisionSite to Allocate Resources Efficiently?

 Quality Control and Quality Assurance  Results Analysis and Trending

When combined with chemometrics techniques, such as principal components analysis (PCA), Spotfire enables viewing of interesting trends in large, multidimensional data sets.

PCA (2 components) For LJ-EDT Data (human/rat liver/microsomes and caco-2 AB/BA) UNSTABLE RHEP 40 20 STABLE RLM 0 -20 -40 -60 -80 UNSTABLE RLM -125 -100 -75 -50 PCA 1 -25 0 25 50 UNSTABLE HLM 75

Spotfire enables viewing of trends that would be difficult to spot otherwise

IS Vals vs Ret Time ASSAY_TYPE ASSAY_TYPE 140000 120000 100000 80000 60000 40000 20000 0 0.2

0.4

0.6

0.8

1 1.2

1.4

1.6

RET_TIME_MIN 0.2

0.4

0.6

0.8

1 1.2

1.4

1.6

Summary

 Spotfire DecisionSite enables powerful interrogation of large data sets  Ability to generate quickly new views of the same dataset is essential in a high-throughput discovery environment   Sometimes, weaknesses in experiment design are uncovered Having a collection of “standard” visualizations greatly facilitates QA  Integration of chemometrics tools (e.g. clustering, PCA, etc) enables researchers to “gain a deeper understanding of their data” (Data  Information)